Protocol Ledger

NCT07442877 · Phase II · COMPLETED

A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Interventional Phase II clinical trial protocol NCT07442877 sponsored by Haisco Pharmaceutical Group Co in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-09-13 Enrollment: 161 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT07442877
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)161 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07442877
Protocol FieldVerified Registry Value
NCT IdentifierNCT07442877
Consolidated Lead SponsorHaisco Pharmaceutical Group Co
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment161 participants (ACTUAL)
Registered Start Date2024-09-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI